These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 2024637

  • 1. Low-dose subcutaneous erythropoietin in continuous ambulatory peritoneal dialysis.
    Rotellar C, Mazzoni MJ, Mosher WF, Aminrazavi M, Bauer A, Rakowski TA, Schreiner GE, Winchester JF.
    Am J Hematol; 1991 May; 37(1):31-3. PubMed ID: 2024637
    [Abstract] [Full Text] [Related]

  • 2. Erythropoietin in continuous ambulatory peritoneal dialysis: experience with subcutaneous administration.
    Eisele G, Bailie GR, Clement C, Wong E.
    Perit Dial Int; 1992 May; 12(1):34-6. PubMed ID: 1543777
    [Abstract] [Full Text] [Related]

  • 3. Correction of anemia using self-administered daily subcutaneous erythropoietin in uremic patients on continuous ambulatory peritoneal dialysis.
    Li PK, Leung CB, Lui SF, Leung JC, Shek AC, Lai KN.
    Int J Artif Organs; 1993 Jul; 16(7):510-4. PubMed ID: 8370605
    [Abstract] [Full Text] [Related]

  • 4. Experience with subcutaneous erythropoietin in CAPD patients.
    Bailie GR, Plitnick R, Eisele G, Clement C, Rasmussen R.
    Adv Perit Dial; 1991 Jul; 7():292-5. PubMed ID: 1680449
    [Abstract] [Full Text] [Related]

  • 5. Recombinant human erythropoietin dosage in children undergoing hemodialysis and continuous ambulatory peritoneal dialysis.
    Sieniawska M, Roszkowska-Blaim M.
    Pediatr Nephrol; 1997 Oct; 11(5):628-30. PubMed ID: 9323294
    [Abstract] [Full Text] [Related]

  • 6. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD.
    Bunke M, Bartlett DK, Brier ME, Golper TA.
    Adv Perit Dial; 1993 Oct; 9():331-5. PubMed ID: 8105957
    [Abstract] [Full Text] [Related]

  • 7. Once weekly subcutaneous erythropoietin is an effective maintenance therapy in the treatment of anemia of end stage renal disease in patients on CAPD.
    Saleh A, Krane NK, Caballero M, Starks E.
    Adv Perit Dial; 1991 Oct; 7():288-91. PubMed ID: 1680448
    [Abstract] [Full Text] [Related]

  • 8. A multicenter study with once a week or once every two weeks high-dose subcutaneous administration of recombinant human erythropoietin in continuous ambulatory peritoneal dialysis.
    Nomoto Y, Kawaguchi Y, Kubota M, Tagawa H, Kubo K, Ogura Y, Shoji T, Kawada Y, Koshikawa S, Mimura N.
    Perit Dial Int; 1994 Oct; 14(1):56-60. PubMed ID: 8312416
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical experience with erythropoietin in continuous ambulatory peritoneal dialysis.
    Jensen SR, Eby SR, McMurray SD, McWilliams MP, Rice C.
    ANNA J; 1992 Dec; 19(6):542-4, 577. PubMed ID: 1292414
    [Abstract] [Full Text] [Related]

  • 12. Intravenous ferric saccharate as an iron supplement in dialysis patients.
    Silverberg DS, Blum M, Peer G, Kaplan E, Iaina A.
    Nephron; 1996 Dec; 72(3):413-7. PubMed ID: 8852489
    [Abstract] [Full Text] [Related]

  • 13. The use of subcutaneous erythropoietin in CAPD patients.
    Piraino B, Johnston JR.
    Clin Nephrol; 1990 Apr; 33(4):200-2. PubMed ID: 2350907
    [Abstract] [Full Text] [Related]

  • 14. Factors related to erythropoietin hypo-responsiveness in patients on chronic peritoneal dialysis.
    Wei M, Bargman JM, Oreopoulos DG.
    Int Urol Nephrol; 2007 Apr; 39(3):935-40. PubMed ID: 17534732
    [Abstract] [Full Text] [Related]

  • 15. Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration.
    Nasu T, Mitui H, Shinohara Y, Hayashida S, Ohtuka H.
    Perit Dial Int; 1992 Apr; 12(4):373-7. PubMed ID: 1420496
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of intravenous and subcutaneous erythropoietin in patients on hemodialysis and continuous ambulatory peritoneal dialysis.
    Lai PC, Wu MS, Huang JY, Huang CC, Leu ML.
    Changgeng Yi Xue Za Zhi; 1994 Jun; 17(2):105-12. PubMed ID: 8069732
    [Abstract] [Full Text] [Related]

  • 17. Treatment of the anemia with human recombinant erythropoietin in CAPD patients.
    Miranda B, Selgas R, Riñon C, Fernandez-Zamorano A, Borrego F, Ortuño F, Lopez-Revuelta K, Torre A, Sanchez Sicilia L.
    Adv Perit Dial; 1990 Jun; 6():296-301. PubMed ID: 1982831
    [Abstract] [Full Text] [Related]

  • 18. Low-dose erythropoietin is effective and safe in children on continuous ambulatory peritoneal dialysis.
    Yalçinkaya F, Tümer N, Cakar N, Ozkaya N.
    Pediatr Nephrol; 1997 Jun; 11(3):350-2. PubMed ID: 9203190
    [Abstract] [Full Text] [Related]

  • 19. The effect of recombinant erythropoietin on the early hematocrit rise after CAPD initiation.
    Golper TA.
    Perit Dial Int; 1992 Jun; 12(1):37-9. PubMed ID: 1543778
    [Abstract] [Full Text] [Related]

  • 20. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
    Cheng IK, Cy C, Chan MK, Yu L, Fang GX, Wei D.
    Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.